Get started
Author

Taochao Tan

ORCID: 0000-0002-3387-0673
Observed ORCID: 0000-0002-3387-0673
OpenAlex ID: A5055578704
Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody
2013 · Tao Dao, Su Yan, et al. · Science Translational Medicine · 191
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape
2022 · Zhenyu Dai, Wei Mu, et al. · Signal Transduction and Targeted Therapy · 93
PDF
The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains
2021 · Zhenyu Dai, Wei Mu, et al. · Molecular Therapy · 67
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
2024 · Jing Pan, Yue Tan, et al. · Nature Medicine · 65
Development of novel humanized CD19 / BAFFR bicistronic chimeric antigen receptor T cells with potent antitumor activity against B‐cell lineage neoplasms
2024 · Sungui Wu, Qian Luo, et al. · British Journal of Haematology · 15
Investigation on recombinant hirudin via oral route
2006 · Xiaodong Cen, Jianquan Ni, et al. · Peptides · 12
Targeting intracellular LMP2 with costimulatory signal–armed antibody-like TCR T cells
2025 · Jiali Cheng, Xuelian Hu, et al. · JCI Insight · 9
PDF
Development and functional characterization of novel fully human anti‐CD19 chimeric antigen receptors for T‐cell therapy
2021 · Zhenyu Dai, Xuelian Hu, et al. · Journal of Cellular Physiology · 8
PDF
Association of Fcgamma Receptor Type 2A and 3A Genotypes with Rheumatoid Arthritis in Chinese Population
2017 · Yining Sun, Lingfei Mo, et al. · Pharmacogenomics · 5
The study on venom proteins of Lapemis hardwickii by cDNA phage display
2011 · Taochao Tan, Xi Xiang, et al. · Toxicology Letters · 5
The development of novel chimeric antigen receptor gamma‐delta T cells against multiple myeloma and single‐cell RNA sequencing analysis
2026 · Yang Hong, Cuiling Zhang, et al. · British Journal of Haematology · 1
Detection of breast cancer-related antigens through cDNA phage-displayed protein microarray
2010 · Qun Bi, Taochao Tan, et al. · Biological Chemistry · 1
Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial (Nature Medicine, (2024), 10.1038/s41591-024-03282-2)
2025 · Jing Pan, Yue Tan, et al. · Newcastle University ePrints (Newcastle Univesity)
Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
2024 · Jing Pan, Yue Tan, et al. · Nature Medicine
PDF
Abstract 2811: CT120, a novel fully human anti-CD19 x anti-CD22 dual targeted chimeric antigen receptor T cell product for the treatment of B-NHL and B-ALL
2022 · Panpan Niu, Qianli Hu, et al. · Cancer Research
Works count: 15
Citation count: 472
H-index: 8
I10-index: 6
Year
Topic
Type